1. 177 Establishing a program of quality improvement in a medical oncology unit. (23rd September 2015) Authors: Tournigand, Christophe; Guy-Coichard, Christian; Bengrine-Lefevre, Leïla; Garcia, Marie-Line; Frédéric, Barbu; de Gramont, Aimery Journal: Quality & safety in health care Issue: Volume 19(2010)Supplement 1 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute tubular necrosis after selective FGFR tyrosine kinase inhibitor therapy. (November 2020) Authors: Moktefi, Anissa; Saldana, Carolina; Stehlé, Thomas; Guillemin, Aude; Sahali, Dil; Ollero, Mario; Henique, Carole; Tournigand, Christophe Journal: European journal of cancer Issue: Volume 139(2020) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials. (February 2021) Authors: Lopes, Guilherme S; Tournigand, Christophe; Olswold, Curtis L; Cohen, Romain; Kempf, Emmanuelle; Saltz, Leonard; Goldberg, Richard M; Hurwitz, Herbert; Fuchs, Charles; de Gramont, Aimery; Shi, Qian Journal: Clinical trials Issue: Volume 18:Number 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review. (January 2021) Authors: Barhli, Aline; Joulia, Marie-Liesse; Tournigand, Christophe; Kempf, Emmanuelle Journal: Critical reviews in oncology/hematology Issue: Volume 157(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of Solid Cancer Treatment Feasibility in Older Patients: A Prospective Cohort Study. (25th February 2014) Authors: Laurent, Marie; Paillaud, Elena; Tournigand, Christophe; Caillet, Philippe; Le Thuaut, Aurélie; Lagrange, Jean-Léon; Beauchet, Olivier; Vincent, Hélène; Carvahlo-Verlinde, Muriel; Culine, Stéphane; Bastuji-Garin, Sylvie; Canouï-Poitrine, Florence Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Assessment of Solid Cancer Treatment Feasibility in Older Patients: A Prospective Cohort Study. (25th February 2014) Authors: Laurent, Marie; Paillaud, Elena; Tournigand, Christophe; Caillet, Philippe; Le Thuaut, Aurélie; Lagrange, Jean‐Léon; Beauchet, Olivier; Vincent, Hélène; Carvahlo‐Verlinde, Muriel; Culine, Stéphane; Bastuji‐Garin, Sylvie; Canouï‐Poitrine, Florence Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bayesian estimation of two‐part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation. Issue 4 (27th February 2023) Authors: Rustand, Denis; van Niekerk, Janet; Rue, Håvard; Tournigand, Christophe; Rondeau, Virginie; Briollais, Laurent Journal: Biometrical journal Issue: Volume 65:Issue 4(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. Issue 15 (November 2015) Authors: Tournigand, Christophe; Chibaudel, Benoist; Samson, Benoit; Scheithauer, Werner; Vernerey, Dewi; Mésange, Paul; Lledo, Gérard; Viret, Frédéric; Ramée, Jean-François; Tubiana-Mathieu, Nicole; Dauba, Jérôme; Dupuis, Olivier; Rinaldi, Yves; Mabro, May; Aucoin, Nathalie; Latreille, Jean; Bonnetain, F... Journal: Lancet oncology Issue: Volume 16:Issue 15(2015) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6. (January 2018) Authors: Laurent, Marie; Des Guetz, Gaétan; Bastuji-Garin, Sylvie; Culine, Stéphane; Caillet, Philippe; Aparicio, Thomas; Audureau, Etienne; Carvahlo-Verlinde, Muriel; Reinald, Nicoleta; Tournigand, Christophe; Landre, Thierry; LeThuaut, Aurélie; Paillaud, Elena; Canouï-Poitrine, Florence Journal: American journal of clinical oncology Issue: Volume 41:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study. (July 2017) Authors: Kempf, Emmanuelle; Tournigand, Christophe; Rochigneux, Philippe; Aubry, Régis; Morin, Lucas Journal: European journal of cancer Issue: Volume 79(2017) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗